Varta
← Back to stories

From The Economic Times

Center-Right Owned by Bennett, Coleman & Co.

The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reach

The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reach

RSS excerpt

For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that remain out of reach, the affordability crisis runs deep. A proposed cap may help, but question remains if it will be enough to change the picture.

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 1 (100%)

Read more news

See all latest stories →